Glenview Capital Management 13F, Q3 2024

Larry Robbins · quarter ending 30 September 2024 · filed 14 November 2024 · SEC CIK 1138995

$4.74B
Filed US book
43
Positions
15.9%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 3 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.

Largest positions, Q3 2024

The 25 largest of 43 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2024 filing.

CompanyTickerValue% of bookvs Q2 2024
CVS HEALTH CORPCVS$751.21M15.9%+30% shares
TENET HEALTHCARE CORPTHC$441.89M9.3%-43% shares
GLOBAL PMTS INCGPN$424.14M8.9%+33% shares
THE CIGNA GROUPCI$364.34M7.7%-19% shares
CORTEVA INCCTVA$308.24M6.5%+3% shares
DXC TECHNOLOGY CODXC$231.86M4.9%+28% shares
CLARIVATE PLC$186.34M3.9%+2% shares
UNIVERSAL HLTH SVCS INCUHS$167.92M3.5%-38% shares
EXPEDIA GROUP INCEXPE$161.45M3.4%+82% shares
TEVA PHARMACEUTICAL INDS LTDTEVA$152.38M3.2%-8% shares
MCKESSON CORPMCK$131.98M2.8%unchanged
ALIGHT INCALITEUR$131.07M2.8%-43% shares
ELEMENT SOLUTIONS INCESI$122.42M2.6%-29% shares
US FOODS HLDG CORPUSFD$111.53M2.4%-27% shares
DUN & BRADSTREET HLDGS INC$110.00M2.3%+165% shares
AMAZON COM INCAMZN$88.59M1.9%+36% shares
VIATRIS INCVTRS$87.91M1.9%+17% shares
MARVELL TECHNOLOGY INCMRVL$84.03M1.8%+35% shares
KNIGHT-SWIFT TRANSN HLDGS INKNX$82.29M1.7%+5% shares
UBER TECHNOLOGIES INCUBER$78.68M1.7%-13% shares
AVIS BUDGET GROUPCAR$58.42M1.2%+26% shares
WESCO INTL INCWCC$46.16M1.0%-28% shares
SEAGATE TECHNOLOGY HLDNGS PL$44.12M0.9%new
MATCH GROUP INC NEWMTCH$43.42M0.9%+224% shares
TELEFLEX INCORPORATEDTFX$40.84M0.9%+35% shares

What changed since Q2 2024

Against the Q2 2024 filing, Glenview Capital Management opened 7 new positions, added to 16, trimmed 18, left 2 unchanged and exited 10. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • SEAGATE TECHNOLOGY HLDNGS PL$44.12M
  • WDC$29.66M
  • DWDPEUR$24.55M
  • SDA$24.49M
  • HSIC$12.73M
  • DNA$3.87M
  • HTZ$1.45M

Exited

  • CNCwas $94.90M
  • HCAwas $62.84M
  • ELVwas $53.42M
  • EXKwas $26.59M
  • VVVwas $20.91M
  • CRSwas $14.25M
  • BHCwas $9.11M
  • GINKGO BIOWORKS HOLDINGS INCwas $8.86M

and 2 more

Added to

  • CVS+30%$751.21M
  • GPN+33%$424.14M
  • CTVA+3%$308.24M
  • DXC+28%$231.86M
  • CLARIVATE PLC+2%$186.34M
  • EXPE+82%$161.45M
  • DUN & BRADSTREET HLDGS INC+165%$110.00M
  • AMZN+36%$88.59M

and 8 more

Trimmed

  • THC-43%$441.89M
  • CI-19%$364.34M
  • UHS-38%$167.92M
  • TEVA-8%$152.38M
  • ALITEUR-43%$131.07M
  • ESI-29%$122.42M
  • USFD-27%$111.53M
  • UBER-13%$78.68M

and 10 more

Other quarters

Source: SEC Form 13F-HR, accession 0000905148-24-003140, filed by GLENVIEW CAPITAL MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.